Zobrazeno 1 - 10
of 48
pro vyhledávání: '"JS Wasser"'
Autor:
JN George, SH Woolf, GE Raskob, JS Wasser, LM Aledort, PJ Ballem, VS Blanchette, JB Bussel, DB Cines, JG Kelton, AE Lichtin, R McMillan, JA Okerbloom, DH Regan, I Warrier
Publikováno v:
Blood. 88:3-40
Autor:
Wasser JS; From the Clinical and Translational Science Institute, Tufts Medical Center and Tufts University School of Medicine, Boston, MA, USA., Greenblatt DJ; From the Clinical and Translational Science Institute, Tufts Medical Center and Tufts University School of Medicine, Boston, MA, USA.
Publikováno v:
Journal of clinical and translational science [J Clin Transl Sci] 2023 Aug 07; Vol. 7 (1), pp. e181. Date of Electronic Publication: 2023 Aug 07 (Print Publication: 2023).
Autor:
Hamid O; Translational Research and Immunotherapy, The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles, California, USA ohamid@theangelesclinic.org., Chiappori AA; Department of Thoracic Oncology, Moffitt Cancer Center, Tampa, Florida, USA., Thompson JA; SCCA, University of Washington, Seattle, Washington, USA., Doi T; Department of Experimental Therapeutics, National Cancer Center Hospital East, Kashiwa, Japan., Hu-Lieskovan S; Department of Medicine, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California, USA., Eskens FALM; Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Ros W; Department of Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Diab A; Department of Melanoma Medical Oncology, UT MD Anderson Cancer Center, Houston, Texas, USA., Spano JP; Medical Oncology, APHP-Sorbonne University, IPLEs Inserm1136, Pitie-Salpetrière Hospital-Paris, Paris, France., Rizvi NA; Department of Medicine, Columbia University Medical Center, New York, New York, USA., Wasser JS; Neag Comprehensive Cancer Center, University of Connecticut School of Medicine, Farmington, Connecticut, USA., Angevin E; Drug Development Department, Institut Gustave Roussy, Villejuif, France., Ott PA; Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Forgie A; Translational Oncology, Pfizer Inc, San Francisco, California, USA., Yang W; Oncology Computational Biology, Pfizer Inc, San Diego, Calfornia, USA., Guo C; Clinical Pharmacology, Pfizer Inc, San Diego, California, USA., Chou J; Early Oncology Development and Clinical Research, Pfizer Inc, San Francisco, California, USA., El-Khoueiry AB; Department of Internal Medicine, Division of Medical Oncology, University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Oct; Vol. 10 (10).
Autor:
Cuker A; Perelman School of Medicine University of Pennsylvania Philadelphia PA USA., Despotovic JM; Department of Pediatrics Baylor College of Medicine Houston TX USA., Grace RF; Dana-Farber/Boston Children's Cancer and Blood Disorders Center Harvard Medical School Boston MA USA., Kruse C; Platelet Disorder Support Association Cleveland OH USA., Lambert MP; Children's Hospital of Philadelphia and the Perelman School of Medicine, University of Pennsylvania Philadelphia PA USA., Liebman HA; University of Southern California, Norris Cancer Hospital Los Angeles CA USA., Lyons RM; Texas Oncology, USONCOLOGY San Antonio TX USA., McCrae KR; Cleveland Clinic, Lerner College of Medicine Cleveland OH USA., Pullarkat V; City of Hope Duarte CA USA., Wasser JS; University of Connecticut Farmington CT USA., Beenhouwer D; Partnership for Health Analytic Research (PHAR), LLC Beverly Hills CA USA., Gibbs SN; Partnership for Health Analytic Research (PHAR), LLC Beverly Hills CA USA., Yermilov I; Partnership for Health Analytic Research (PHAR), LLC Beverly Hills CA USA., Broder MS; Partnership for Health Analytic Research (PHAR), LLC Beverly Hills CA USA.
Publikováno v:
Research and practice in thrombosis and haemostasis [Res Pract Thromb Haemost] 2020 Dec 08; Vol. 5 (1), pp. 69-80. Date of Electronic Publication: 2020 Dec 08 (Print Publication: 2021).
Autor:
Aggarwal C; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania. charu.aggarwal@pennmedicine.upenn.edu., Thompson JC; Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Chien AL; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Quinn KJ; Guardant Health Inc., Redwood City, California., Hwang WT; Department of Biostatistics, Epidemiology and Informatics, University of Pennsylvania, Philadelphia, Pennsylvania., Black TA; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Yee SS; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Christensen TE; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., LaRiviere MJ; Division of Radiation Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Silva BA; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Banks KC; Guardant Health Inc., Redwood City, California., Nagy RJ; Guardant Health Inc., Redwood City, California., Helman E; Guardant Health Inc., Redwood City, California., Berman AT; Division of Radiation Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Ciunci CA; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Singh AP; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Wasser JS; Neag Comprehensive Cancer Center, UConn Health, University of Connecticut, Farmington, Connecticut., Bauml JM; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Langer CJ; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Cohen RB; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Carpenter EL; Division of Hematology/Oncology, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2020 May 15; Vol. 26 (10), pp. 2354-2361. Date of Electronic Publication: 2020 Feb 26.
Autor:
Bylsma LC; EpidStat Institute, Ann Arbor, Michigan., Fryzek JP; EpidStat Institute, Ann Arbor, Michigan., Cetin K; Center for Observational Research, Amgen, Inc., Thousand Oaks, California., Callaghan F; Center for Observational Research, Amgen, Inc., Thousand Oaks, California., Bezold C; EpidStat Institute, Ann Arbor, Michigan., Mehta B; Global Development, Amgen, Inc., Thousand Oaks, California., Wasser JS; Carole and Ray Neag Comprehensive Cancer Center, University of Connecticut School of Medicine, Farmington, Connecticut.
Publikováno v:
American journal of hematology [Am J Hematol] 2019 Jan; Vol. 94 (1), pp. 118-132. Date of Electronic Publication: 2018 Oct 21.
Autor:
Mitchell TC; Tara C. Mitchell, University of Pennsylvania; Anthony J. Olszanski, Fox Chase Cancer Center, Philadelphia, PA; Omid Hamid and Ani S. Balmanoukian, The Angeles Clinic and Research Institute, Los Angeles, CA; David C. Smith, University of Michigan, Ann Arbor, MI; Todd M. Bauer, Tennessee Oncology, Nashville, TN; Jeffrey S. Wasser, University of Connecticut School of Medicine, Farmington, CT; Jason J. Luke and Thomas F. Gajewski, University of Chicago Medicine, Chicago, IL; Emmett V. Schmidt, Merck & Co, Kenilworth, NJ; and Yufan Zhao, Xiaohua Gong, Janet Maleski, and Lance Leopold, Incyte Corporation, Wilmington, DE., Hamid O; Tara C. Mitchell, University of Pennsylvania; Anthony J. Olszanski, Fox Chase Cancer Center, Philadelphia, PA; Omid Hamid and Ani S. Balmanoukian, The Angeles Clinic and Research Institute, Los Angeles, CA; David C. Smith, University of Michigan, Ann Arbor, MI; Todd M. Bauer, Tennessee Oncology, Nashville, TN; Jeffrey S. Wasser, University of Connecticut School of Medicine, Farmington, CT; Jason J. Luke and Thomas F. Gajewski, University of Chicago Medicine, Chicago, IL; Emmett V. Schmidt, Merck & Co, Kenilworth, NJ; and Yufan Zhao, Xiaohua Gong, Janet Maleski, and Lance Leopold, Incyte Corporation, Wilmington, DE., Smith DC; Tara C. Mitchell, University of Pennsylvania; Anthony J. Olszanski, Fox Chase Cancer Center, Philadelphia, PA; Omid Hamid and Ani S. Balmanoukian, The Angeles Clinic and Research Institute, Los Angeles, CA; David C. Smith, University of Michigan, Ann Arbor, MI; Todd M. Bauer, Tennessee Oncology, Nashville, TN; Jeffrey S. Wasser, University of Connecticut School of Medicine, Farmington, CT; Jason J. Luke and Thomas F. Gajewski, University of Chicago Medicine, Chicago, IL; Emmett V. Schmidt, Merck & Co, Kenilworth, NJ; and Yufan Zhao, Xiaohua Gong, Janet Maleski, and Lance Leopold, Incyte Corporation, Wilmington, DE., Bauer TM; Tara C. Mitchell, University of Pennsylvania; Anthony J. Olszanski, Fox Chase Cancer Center, Philadelphia, PA; Omid Hamid and Ani S. Balmanoukian, The Angeles Clinic and Research Institute, Los Angeles, CA; David C. Smith, University of Michigan, Ann Arbor, MI; Todd M. Bauer, Tennessee Oncology, Nashville, TN; Jeffrey S. Wasser, University of Connecticut School of Medicine, Farmington, CT; Jason J. Luke and Thomas F. Gajewski, University of Chicago Medicine, Chicago, IL; Emmett V. Schmidt, Merck & Co, Kenilworth, NJ; and Yufan Zhao, Xiaohua Gong, Janet Maleski, and Lance Leopold, Incyte Corporation, Wilmington, DE., Wasser JS; Tara C. Mitchell, University of Pennsylvania; Anthony J. Olszanski, Fox Chase Cancer Center, Philadelphia, PA; Omid Hamid and Ani S. Balmanoukian, The Angeles Clinic and Research Institute, Los Angeles, CA; David C. Smith, University of Michigan, Ann Arbor, MI; Todd M. Bauer, Tennessee Oncology, Nashville, TN; Jeffrey S. Wasser, University of Connecticut School of Medicine, Farmington, CT; Jason J. Luke and Thomas F. Gajewski, University of Chicago Medicine, Chicago, IL; Emmett V. Schmidt, Merck & Co, Kenilworth, NJ; and Yufan Zhao, Xiaohua Gong, Janet Maleski, and Lance Leopold, Incyte Corporation, Wilmington, DE., Olszanski AJ; Tara C. Mitchell, University of Pennsylvania; Anthony J. Olszanski, Fox Chase Cancer Center, Philadelphia, PA; Omid Hamid and Ani S. Balmanoukian, The Angeles Clinic and Research Institute, Los Angeles, CA; David C. Smith, University of Michigan, Ann Arbor, MI; Todd M. Bauer, Tennessee Oncology, Nashville, TN; Jeffrey S. Wasser, University of Connecticut School of Medicine, Farmington, CT; Jason J. Luke and Thomas F. Gajewski, University of Chicago Medicine, Chicago, IL; Emmett V. Schmidt, Merck & Co, Kenilworth, NJ; and Yufan Zhao, Xiaohua Gong, Janet Maleski, and Lance Leopold, Incyte Corporation, Wilmington, DE., Luke JJ; Tara C. Mitchell, University of Pennsylvania; Anthony J. Olszanski, Fox Chase Cancer Center, Philadelphia, PA; Omid Hamid and Ani S. Balmanoukian, The Angeles Clinic and Research Institute, Los Angeles, CA; David C. Smith, University of Michigan, Ann Arbor, MI; Todd M. Bauer, Tennessee Oncology, Nashville, TN; Jeffrey S. Wasser, University of Connecticut School of Medicine, Farmington, CT; Jason J. Luke and Thomas F. Gajewski, University of Chicago Medicine, Chicago, IL; Emmett V. Schmidt, Merck & Co, Kenilworth, NJ; and Yufan Zhao, Xiaohua Gong, Janet Maleski, and Lance Leopold, Incyte Corporation, Wilmington, DE., Balmanoukian AS; Tara C. Mitchell, University of Pennsylvania; Anthony J. Olszanski, Fox Chase Cancer Center, Philadelphia, PA; Omid Hamid and Ani S. Balmanoukian, The Angeles Clinic and Research Institute, Los Angeles, CA; David C. Smith, University of Michigan, Ann Arbor, MI; Todd M. Bauer, Tennessee Oncology, Nashville, TN; Jeffrey S. Wasser, University of Connecticut School of Medicine, Farmington, CT; Jason J. Luke and Thomas F. Gajewski, University of Chicago Medicine, Chicago, IL; Emmett V. Schmidt, Merck & Co, Kenilworth, NJ; and Yufan Zhao, Xiaohua Gong, Janet Maleski, and Lance Leopold, Incyte Corporation, Wilmington, DE., Schmidt EV; Tara C. Mitchell, University of Pennsylvania; Anthony J. Olszanski, Fox Chase Cancer Center, Philadelphia, PA; Omid Hamid and Ani S. Balmanoukian, The Angeles Clinic and Research Institute, Los Angeles, CA; David C. Smith, University of Michigan, Ann Arbor, MI; Todd M. Bauer, Tennessee Oncology, Nashville, TN; Jeffrey S. Wasser, University of Connecticut School of Medicine, Farmington, CT; Jason J. Luke and Thomas F. Gajewski, University of Chicago Medicine, Chicago, IL; Emmett V. Schmidt, Merck & Co, Kenilworth, NJ; and Yufan Zhao, Xiaohua Gong, Janet Maleski, and Lance Leopold, Incyte Corporation, Wilmington, DE., Zhao Y; Tara C. Mitchell, University of Pennsylvania; Anthony J. Olszanski, Fox Chase Cancer Center, Philadelphia, PA; Omid Hamid and Ani S. Balmanoukian, The Angeles Clinic and Research Institute, Los Angeles, CA; David C. Smith, University of Michigan, Ann Arbor, MI; Todd M. Bauer, Tennessee Oncology, Nashville, TN; Jeffrey S. Wasser, University of Connecticut School of Medicine, Farmington, CT; Jason J. Luke and Thomas F. Gajewski, University of Chicago Medicine, Chicago, IL; Emmett V. Schmidt, Merck & Co, Kenilworth, NJ; and Yufan Zhao, Xiaohua Gong, Janet Maleski, and Lance Leopold, Incyte Corporation, Wilmington, DE., Gong X; Tara C. Mitchell, University of Pennsylvania; Anthony J. Olszanski, Fox Chase Cancer Center, Philadelphia, PA; Omid Hamid and Ani S. Balmanoukian, The Angeles Clinic and Research Institute, Los Angeles, CA; David C. Smith, University of Michigan, Ann Arbor, MI; Todd M. Bauer, Tennessee Oncology, Nashville, TN; Jeffrey S. Wasser, University of Connecticut School of Medicine, Farmington, CT; Jason J. Luke and Thomas F. Gajewski, University of Chicago Medicine, Chicago, IL; Emmett V. Schmidt, Merck & Co, Kenilworth, NJ; and Yufan Zhao, Xiaohua Gong, Janet Maleski, and Lance Leopold, Incyte Corporation, Wilmington, DE., Maleski J; Tara C. Mitchell, University of Pennsylvania; Anthony J. Olszanski, Fox Chase Cancer Center, Philadelphia, PA; Omid Hamid and Ani S. Balmanoukian, The Angeles Clinic and Research Institute, Los Angeles, CA; David C. Smith, University of Michigan, Ann Arbor, MI; Todd M. Bauer, Tennessee Oncology, Nashville, TN; Jeffrey S. Wasser, University of Connecticut School of Medicine, Farmington, CT; Jason J. Luke and Thomas F. Gajewski, University of Chicago Medicine, Chicago, IL; Emmett V. Schmidt, Merck & Co, Kenilworth, NJ; and Yufan Zhao, Xiaohua Gong, Janet Maleski, and Lance Leopold, Incyte Corporation, Wilmington, DE., Leopold L; Tara C. Mitchell, University of Pennsylvania; Anthony J. Olszanski, Fox Chase Cancer Center, Philadelphia, PA; Omid Hamid and Ani S. Balmanoukian, The Angeles Clinic and Research Institute, Los Angeles, CA; David C. Smith, University of Michigan, Ann Arbor, MI; Todd M. Bauer, Tennessee Oncology, Nashville, TN; Jeffrey S. Wasser, University of Connecticut School of Medicine, Farmington, CT; Jason J. Luke and Thomas F. Gajewski, University of Chicago Medicine, Chicago, IL; Emmett V. Schmidt, Merck & Co, Kenilworth, NJ; and Yufan Zhao, Xiaohua Gong, Janet Maleski, and Lance Leopold, Incyte Corporation, Wilmington, DE., Gajewski TF; Tara C. Mitchell, University of Pennsylvania; Anthony J. Olszanski, Fox Chase Cancer Center, Philadelphia, PA; Omid Hamid and Ani S. Balmanoukian, The Angeles Clinic and Research Institute, Los Angeles, CA; David C. Smith, University of Michigan, Ann Arbor, MI; Todd M. Bauer, Tennessee Oncology, Nashville, TN; Jeffrey S. Wasser, University of Connecticut School of Medicine, Farmington, CT; Jason J. Luke and Thomas F. Gajewski, University of Chicago Medicine, Chicago, IL; Emmett V. Schmidt, Merck & Co, Kenilworth, NJ; and Yufan Zhao, Xiaohua Gong, Janet Maleski, and Lance Leopold, Incyte Corporation, Wilmington, DE.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2018 Nov 10; Vol. 36 (32), pp. 3223-3230. Date of Electronic Publication: 2018 Sep 28.
Autor:
Ryan JM; Department of Immunology, School of Medicine, UConn Health, Farmington, CT, 06030, USA., Mittal P; Department of Immunology, School of Medicine, UConn Health, Farmington, CT, 06030, USA., Menoret A; Department of Immunology, School of Medicine, UConn Health, Farmington, CT, 06030, USA., Svedova J; Department of Immunology, School of Medicine, UConn Health, Farmington, CT, 06030, USA., Wasser JS; Department of Medicine, School of Medicine, UConn Health, Farmington, CT, 06030, USA., Adler AJ; Department of Immunology, School of Medicine, UConn Health, Farmington, CT, 06030, USA. aadler@uchc.edu., Vella AT; Department of Immunology, School of Medicine, UConn Health, Farmington, CT, 06030, USA. vella@uchc.edu.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2018 Apr; Vol. 67 (4), pp. 605-613. Date of Electronic Publication: 2018 Jan 11.
Autor:
Li S; a Chronic Disease Research Group , Minneapolis Medical Research Foundation , Minneapolis , MN , USA., Molony JT; a Chronic Disease Research Group , Minneapolis Medical Research Foundation , Minneapolis , MN , USA., Cetin K; b Center for Observational Research , Amgen Inc. , Thousand Oaks , CA , USA., Wasser JS; c Carole and Ray Neag Comprehensive Cancer Center , University of Connecticut School of Medicine , Farmington , CT , USA., Altomare I; d Department of Medicine , Duke University School of Medicine , Durham , NC , USA.
Publikováno v:
Current medical research and opinion [Curr Med Res Opin] 2018 Feb; Vol. 34 (2), pp. 209-216. Date of Electronic Publication: 2017 Aug 24.
Autor:
Lin J; Amgen Inc, Thousand Oaks, California., Zhang X; Amgen Inc, Thousand Oaks, California; University of Southern California, Los Angeles, California., Li X; Amgen Inc, Thousand Oaks, California., Chandler D; Amgen Inc, Thousand Oaks, California. Electronic address: dchandle@amgen.com., Altomare I; Division of Medical Oncology, Duke University Medical Center, Durham, North Carolina., Wasser JS; Carole and Ray Neag Comprehensive Cancer Center, University of Connecticut School of Medicine, Farmington, Connecticut; Department of Medicine, Division of Hematology-Oncology, University of Connecticut School of Medicine, Farmington, Connecticut., Cetin K; Amgen Inc, Cambridge, Massachusetts.
Publikováno v:
Clinical therapeutics [Clin Ther] 2017 Mar; Vol. 39 (3), pp. 603-609.e1. Date of Electronic Publication: 2017 Feb 09.